Categories AlphaGraphs, Earnings, Technology

Earnings: Highlights of International Business Machines (IBM) Q2 results

International Business Machines Corporation (NYSE: IBM) on Wednesday announced operating results for the second quarter of 2023, reporting a decline in adjusted earnings.

IBM Q2 2023 earnings infographic

Total revenues were $15.5 billion in the second quarter of 2023, which is broadly unchanged from the prior-year period. Meanwhile, adjusted earnings from continuing operations declined to $2.18 per share from $2.31 per share in the year-ago period. On an unadjusted basis, June-quarter net profit was $1.58 billion or $1.72 per share, compared to $1.39 billion or $1.53 per share in the corresponding period of 2022.

“We continue to respond to the needs of our clients who seek trusted, enterprise AI solutions, and we are particularly excited about the response to the recently launched watsonx AI platform. Finally, we remain confident in our revenue and free cash flow growth expectations for the full year,” said IBM’s CEO Arvind Krishna.

Prior Performance

  • IBM Q3 2022 earnings infographic
  • International Business Machines Q4 2022 earnings infographic


Stocks you may like:

Apple (AAPL) Stock

Microsoft (MSFT) Stock

Alphabet (GOOGL) Stock

International Business Machines Corp. (IBM) Stock


Most Popular

Nike (NKE) looks set to beat hurdles and build a brighter future

Nike, Inc. (NYSE: NKE) has long been ruling the sportswear market but the company had its share of problems when headwinds like the pandemic and economic slowdown hit the business

Electronic Arts (EA): A few points to keep in mind if you have an eye on this gaming company

Shares of Electronic Arts Inc. (NASDAQ: EA) stayed green on Friday. The stock has dropped 7% over the past three months. The video game industry has been facing challenges as

Petros Pharma is focused on establishing mechanisms for Rx-to-OTC switch: CCO Fady Boctor

Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) is a pharma company focused on identifying, developing, and commercializing therapeutics for men's health issues. It operates mainly through the business segments of Prescription Medications

Add Comment
Viewing Highlight